$6.5 billion Henry Schein, a Melville, N.Y.-based distributor of healthcare products and services to office-based practitioners, has promoted Sergio Tejeda to director of regulatory operations and compliance.

Tejeda joined Henry Schein in 1990 and spent his first eight years at the company as the returns supervisor. In 2006, he was promoted to regulatory affairs manager and assumed responsibility for the Regulatory Affairs team at GIV (General Injectables & Vaccines), a Henry Schein Company.

In his expanded role, in addition to his ongoing operational compliance responsibilities, Tejeda will be responsible for the oversight and management of Henry Schein’s adverse event and product quality processes and related regulatory activities. In this area, his initial focus will be to integrate and centralize this vital function with the company’s other core regulatory operations to identify opportunities, leverage resources, and globalize best practices.